Patents by Inventor Miriam K. Franchini

Miriam K. Franchini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090004277
    Abstract: Disclosed is a nanoparticle dispersion comprising nanoparticles dispersed in an aqueous medium in the presence of at least one stabilizer. The nanoparticles comprise at least lactam compound of formula I: wherein R1, R2, R3, R4, R5, R6, R7, and Q are defined herein. A method is provided of the parenteral administration of the nanoparticle dispersion as a treatment for cancer or another proliferative disease. Also, a solid nanoparticulate composition comprising the nanoparticles of the lactam compound, and a method of administration are disclosed.
    Type: Application
    Filed: May 16, 2005
    Publication date: January 1, 2009
    Inventors: Miriam K. Franchini, Thomas A. Haby, Elaine Liversidge
  • Patent number: 7053069
    Abstract: Pharmaceutical compositions containing C-21 modified epothilone derivatives, methods for their preparation and dosing regimen for administration of these epothilone compounds are provided. The compositions are stable and readily prepared for administration by dissolution in aqueous vehicles suitable for intravenous administration. A process for formulating C-21 modified epothilone derivatives for oral and parenteral administration is disclosed.
    Type: Grant
    Filed: May 13, 2003
    Date of Patent: May 30, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Francis Y. F. Lee, Thomas A. Haby, Vijay H. Naringrekar, Krishnaswamy S. Raghavan, Miriam K. Franchini
  • Publication number: 20040053978
    Abstract: Pharmaceutical compositions containing C-21 modified epothilone derivatives, methods for their preparation and dosing regimen for administration of these epothilone compounds are provided. The compositions are stable and readily prepared for administration by dissolution in aqueous vehicles suitable for intravenous administration. A process for formulating C-21 modified epothilone derivatives for oral and parenteral administration is disclosed.
    Type: Application
    Filed: May 13, 2003
    Publication date: March 18, 2004
    Inventors: Francis Y. F. Lee, Thomas A. Haby, Vijay H. Naringrekar, Krishnaswamy S. Raghavan, Miriam K. Franchini
  • Patent number: 5496809
    Abstract: Stable solutions of rebeccamycin analog consist essentially of (a) water, (b) 8-N-(diethylaminoethyl)rebeccamycin in an effective dosage amount, and (c) pharmaceutically acceptable acid such that the presence of a molar equivalence thereof would solubilize (b), said acid being present in excess of said molar equivalence to provide a stabilizing pH ranging from 3 to 4, preferably from 3.0 to 3.6. A preferred solution contains 10 mg/ml of the free base and tartaric acid in equimolar amount with the free base to provide a pH of 3.5. Preferably, the solution is prepared by forming a suspension of 8-N-(diethylaminoethyl)rebeccamycin in water and adding acid to provide a pH ranging from 3 to 4.
    Type: Grant
    Filed: May 10, 1989
    Date of Patent: March 5, 1996
    Assignee: Bristol-Myers Squibb Co
    Inventors: Ubrani V. Venkataram, Miriam K. Franchini, Joseph B. Bogardus